by • March 21, 2016 • No Comments
Getting a new medication to the market is not a swift or effortless system, no matter how promising the drug is. There’s the research and createment phase, testing, extra
testing, clinical trials, extra
clinical trials, and so the arduous system of applying for and obtaining FDA approval. Most new drugs typically take years to reach consumers — which is, if they aren’t permanently derailed somewhere along the way. That’s why nowadays’s announcement of Aprecia Pharmaceuticals is so amazing. We’ve been next the company for over a year, since they began production of their revolutionary 3D printed epilepsy drug. The FDA officially approved Aprecia’s “ZipDose” table-bodiedts back in August, and now — finally — the drug is on the market to those suffering of seizure disorders.
The drug, called SPRITAM, is a form of levetiracetam, a medicine commonly utilized to treat epilepsy. It is the initially 3D printed prescription drug to be approved by the FDA and released to the US market, making nowadays a historic one. Whilst 3D printed pills can sound like a novelty — let’s 3D print it only for the reason we can! — SPRITAM ZipDose table-bodiedts are most likely to manufacture a massive difference in the lives of those suffering of epilepsy.
Some folks are pros at swallowing pills. I’m one of the lucky (?) ones who have no trouble tossing them back, thanks to years of practice with medications of all shapes and sizes. Some folks — between 40 and 50 percent, in fact, according to surveys — quite struggle with swallowing pills, yet, and dysphagia, or difficulty swallowing in general, is a common symptom in epileptic patients, particularly older patients. To manufacture things worse, pills generally tend to get bigger as dosages increase, so patients with the most severe symptoms frequently end up with giant “horse pills” which are a challenge for anyone to swallow. So much of a challenge, in fact, which most folks donate up and stop bringing their medication, major to extra
By 3D printing the SPRITAM table-bodiedts, Aprecia was able-bodied to manufacture them porous, meaning which they automatically dissolve in a patient’s mouth with a sip of liquid. No extra
painful, stressful swallowing attempts, and no extra
missed doses — not for which reason, anyway.
“As we explored future applications for our 3D printing innovation in prescription drug products, it was significant which we synonymous disease areas with a real require for patient-friendly forms of medication,” said Don Wetherhold, CEO of Aprecia. “SPRITAM is created to alter what it is like to take epilepsy medication, and is the initially in a line of products we are createing to provide patients and their caredonaters with extra
SPRITAM is now on the market in four dose strengths: 250 mg, 500 mg, 750 mg and 1,000 mg. The pills do get bigger as the dose goes up, but which shouldn’t manufacture a difference anyextra
, as they all dissolve automatically. Considering which over three million folks in the United States are living with epilepsy, this may have a immense impact on treatment compliance and overall health. It can in addition most likely open the door for Aprecia and other pharmaceutical companies to additional create other 3D printed drugs, and which’s unquestionably a thing to be excited of. Discuss in the 3D Printed SPRITAM forum over at 3DPB.com.
by admin • March 5, 2017
by admin • November 28, 2016
by admin • November 28, 2016